What is Bevacizumab?

Category: Prescription Drugs

Most popular types: Avastin

false

See also: Paclitaxel-bevacizumab

Bevacizumab is a monoclonal antibody and vascular endothelial growth factor inhibitor used for various types of cancer. It has also been used for recurrent ovarian cancer and age-related macular degeneration.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Macular degeneration 36 3
Adenocarcinoma (non-small cell lung cancer) 21 3
Lung cancer 13 0
Non-small cell lung cancer 7 0
Ovarian cancer 7 3
Colon cancer 6 2

Show all 31 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 6
Moderate 4
Mild 4
None 7

Commonly reported side effects and conditions associated with Bevacizumab

Side effect Patients Percentage
Fatigue 2
Abdominal pain 1
Allergic rhinitis 1
Anorexia nervosa 1
Body hair loss 1
Cervical radiculopathy 1

Show all 18 reported side effects

Dosages

Based on patients currently taking Bevacizumab

Dosage Patients Percentage
25 mg every 6 weeks 1
25 mg daily 1

Why patients stopped taking Bevacizumab

Multiple reasons could be selected

Reason Patients Percentage
Doctor's advice 4
Other 4
Side effects too severe 4
Course of treatment ended 3
Did not seem to work 1
Expense 1
Personal research 1
See all 13 patients who've stopped taking Bevacizumab

Duration

Currently taking Bevacizumab

Duration Patients Percentage
1 - 6 months 1
5 - 10 years 1

Stopped taking Bevacizumab

Duration Patients Percentage
Less than 1 month 1
1 - 6 months 5
6 months - 1 year 4
1 - 2 years 1
2 - 5 years 2
Adherence
Adherence Evaluations Percentage
Always 14
Usually 2
Sometimes 2
Never taken as prescribed 3
Burden
Burden Evaluations Percentage
Very hard to take 4
Somewhat hard to take 8
A little hard to take 5
Not at all hard to take 4
Cost per month
Cost per month Evaluations Percentage
$200+ 4
$100-199 0
$50-99 0
$25-49 1
< $25 1
Not specified 15

What people switch to and from

Patients started taking Bevacizumab after stopping:

Treatment Patients Percentage
Carboplatin 2
Chemotherapy 1
Gemcitabine (Gemzar) 1
Nivolumab (Opdivo) 1
Paclitaxel (Taxol) 1

Show all 6 treatments patients report switching from

Patients stopped taking Bevacizumab and switched to:

Treatment Patients Percentage
Nivolumab (Opdivo) 2
Aflibercept (Eylea) 1
Ceritinib (Zykadia) 1
Ipilimumab (Yervoy) 1
Pemetrexed (Alimta) 1
Last updated:

1 patient evaluation for Bevacizumab

Mar 19, 2013 (Started Aug 23, 2012)

  • Effectiveness
    Can't tell (for glioblastoma)
  • Side effects
    Moderate (tongue swelling, rash or skin problems, sore tongue)
  • Adherence
    Always
  • Burden
    Somewhat hard to take
Dosage: 25 mg Every Other Week
Advice & Tips: I got a skin abrassion feeling on 3 spots. The only problematic one was my tongue which felt as though someone took a nail file to it. This is a big reason for the pause in Avastin. I want to see it it changes anything there.

Feb 19, 2013 (Started Aug 23, 2012)

  • Effectiveness
    Slight (for glioblastoma)
  • Side effects
    Moderate (tongue swelling, rash or skin problems, sore tongue)
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 25 mg Every Other Week

  • 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for Bevacizumab